Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
7.51
+0.09 (1.21%)
Apr 25, 2025, 12:23 PM EDT - Market open
Amneal Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -116.89 | -83.99 | -129.99 | 10.62 | 91.06 | Upgrade
|
| Depreciation & Amortization | 236.19 | 229.4 | 240.18 | 233.41 | 235.39 | Upgrade
|
| Other Amortization | 29.1 | 11.55 | 8.6 | 9.2 | 8.68 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | -0.12 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.92 | 66.93 | 24.08 | 28.55 | 36.72 | Upgrade
|
| Stock-Based Compensation | 27.77 | 26.82 | 31.85 | 28.41 | 20.75 | Upgrade
|
| Other Operating Activities | 122.08 | 142.05 | -49.67 | 65.21 | 47.85 | Upgrade
|
| Change in Accounts Receivable | -162.64 | 126.29 | -79.72 | -23.62 | 16.79 | Upgrade
|
| Change in Inventory | -130.53 | -126.18 | -102.4 | -49.02 | -113.78 | Upgrade
|
| Change in Accounts Payable | 235.14 | -94.45 | 109.57 | -43.93 | 0.31 | Upgrade
|
| Change in Other Net Operating Assets | 53.96 | 47.15 | 12.6 | -17.03 | 35.37 | Upgrade
|
| Operating Cash Flow | 295.1 | 345.58 | 65.1 | 241.82 | 379 | Upgrade
|
| Operating Cash Flow Growth | -14.61% | 430.84% | -73.08% | -36.20% | 22128.80% | Upgrade
|
| Capital Expenditures | -60.34 | -46.8 | -48.8 | -50.94 | -61.84 | Upgrade
|
| Cash Acquisitions | - | - | -84.71 | -146.54 | -251.36 | Upgrade
|
| Divestitures | 11.99 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -14.65 | -22.39 | -41.8 | -1.7 | -4.35 | Upgrade
|
| Other Investing Activities | - | - | 1 | 5 | - | Upgrade
|
| Investing Cash Flow | -63 | -69.19 | -174.31 | -194.18 | -317.55 | Upgrade
|
| Short-Term Debt Issued | 48 | 219 | 85 | - | - | Upgrade
|
| Long-Term Debt Issued | - | 217.73 | - | - | 180 | Upgrade
|
| Total Debt Issued | 48 | 436.73 | 85 | - | 180 | Upgrade
|
| Short-Term Debt Repaid | -44.2 | - | - | -1 | - | Upgrade
|
| Long-Term Debt Repaid | -188.92 | -414.08 | -123.27 | -78.18 | -37.01 | Upgrade
|
| Total Debt Repaid | -233.12 | -414.08 | -123.27 | -79.18 | -37.01 | Upgrade
|
| Net Debt Issued (Repaid) | -185.12 | 22.65 | -38.27 | -79.18 | 142.99 | Upgrade
|
| Issuance of Common Stock | 1.15 | 0.45 | 0.66 | 0.85 | 0.32 | Upgrade
|
| Repurchase of Common Stock | -7.95 | -2.38 | -3.57 | -2.66 | -0.86 | Upgrade
|
| Other Financing Activities | -19.88 | -233.3 | -65.44 | -57.13 | -10.64 | Upgrade
|
| Financing Cash Flow | -211.79 | -212.57 | -106.62 | -138.12 | 131.81 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1 | 0.07 | -5.68 | 0.1 | 1.04 | Upgrade
|
| Net Cash Flow | 19.31 | 63.88 | -221.51 | -90.38 | 194.3 | Upgrade
|
| Free Cash Flow | 234.76 | 298.78 | 16.3 | 190.88 | 317.17 | Upgrade
|
| Free Cash Flow Growth | -21.43% | 1732.42% | -91.46% | -39.82% | - | Upgrade
|
| Free Cash Flow Margin | 8.40% | 12.48% | 0.74% | 9.12% | 15.92% | Upgrade
|
| Free Cash Flow Per Share | 0.76 | 1.70 | 0.11 | 1.26 | 2.13 | Upgrade
|
| Cash Interest Paid | 263.52 | 192.81 | 142.72 | 121.75 | 130.19 | Upgrade
|
| Cash Income Tax Paid | 15.22 | 2.5 | 12.65 | 15.56 | -100.14 | Upgrade
|
| Levered Free Cash Flow | 253.45 | 307.26 | 120.14 | 217.65 | 153.82 | Upgrade
|
| Unlevered Free Cash Flow | 385.98 | 427.36 | 210.53 | 293.65 | 236.39 | Upgrade
|
| Change in Net Working Capital | 20.72 | -70.71 | 95.92 | 50.9 | 44.6 | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.